New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. A comment on: Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients. by Calderon-Goercke et al.

被引:0
|
作者
Guarda, M. [1 ]
Araoz, P. A. [2 ]
Ghaffar, U. [1 ]
Warrington, K. J. [1 ]
Koster, M. J. [1 ]
机构
[1] Mayo Clin, Div Rheumatol, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Dept Radiol, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:989 / 990
页数:2
相关论文
共 4 条
  • [1] Reply to New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy by Guarda et al.
    Gonzalez-Gay, M. A.
    Hernandez, J. L.
    Blanco, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (04) : 991 - 991
  • [2] Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
    Calderon-Goercke, M.
    Loricera, J.
    Moriano, C.
    Castaneda, S.
    Narvaez, J.
    Aldasoro, V.
    Maiz, O.
    Melero, R.
    Villa, J. I.
    Vela, P.
    Romero-Yuste, S.
    Callejas, J. L.
    de Miguel, E.
    Galindez-Agirregoikoa, E.
    Sivera, F.
    Fernandez-Lopez, J. C.
    Galisteo, C.
    Ferraz-Amaro, I.
    Sanchez-Martin, J.
    Sanchez-Bilbao, L.
    Gonzalez-Gay, M. A.
    Hernandez, J. L.
    Blanco, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (04) : 829 - 836
  • [3] OPTIMIZATION OF TOCILIZUMAB THERAPY IN GIANT CELL ARTERITIS. A MULTICENTER REAL-LIFE STUDY OF 471 PATIENTS.
    Alvarez-Reguera, C.
    Calderon-Goercke, M.
    Loricera, J.
    Moriano, C.
    Castaneda, S.
    Narvaez, J.
    Aldasoro, V.
    Maiz, O.
    Melero, R.
    Villa-Blanco, I.
    Vela-Casasempere, P.
    Romero-Yuste, S.
    Callejas-Rubio, J. L.
    De Miguel, E.
    Galindez-Agirregoikoa, E.
    Sivera, F.
    Fernandez-Lopez, C.
    Galisteo, C.
    Ferraz-Amaro, I.
    Sanchez-Martin, J.
    Sanchez-Bilbao, L.
    Hernandez Hernandez, J. L.
    Gonzalez-Gay, M. A.
    Blancoon, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 692 - 693
  • [4] OPTIMIZATION OF TOCILIZUMAB THERAPY IN GIANT CELL ARTERITIS. A MULTICENTER REAL-LIFE STUDY OF 134 PATIENTS
    Calderon-Goercke, M.
    Prieto-Pena, D.
    Castaneda, S.
    Moriano, C.
    Becerra-Fernandez, E.
    Revenga, M.
    Alvarez-Rivas, N.
    Galisteo, C.
    Prior-Espanol, A.
    Galindez, E.
    Hidalgo, C.
    Manrique Arija, S.
    De Miguel, E.
    Salgado-Perez, E.
    Aldasoro, V.
    Villa-Blanco, I.
    Romero-Yuste, S.
    Narvaez, J.
    Gomez-Arango, C.
    Perez-Pampin, E.
    Melero, R.
    Sivera, F.
    Olive, A.
    Alvarez del Buergo, M.
    Marena Rojas, L.
    Fernandez-Lopez, C.
    Navarro, F.
    Raya, E.
    Arca, B.
    Solans-Laque, R.
    Conesa, A.
    Vazquez, C.
    Roman-Ivorra, J. A.
    Lluch, P.
    Vela-Casasempere, P.
    Torres-Martin, C.
    Nieto, J. C.
    Ordas-Calvo, C.
    Luna-Gomez, C.
    Toyos Saenz de Miera, F. J.
    Fernandez-Llanio, N.
    Garcia, A.
    Hernandez, J. L.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 23 - 23